Infection Prevention and Control
The buzzword these days in quality improvement is “HIIN.” That’s short for Hospital Improvement Innovation Networks, part of the continuation of the Partnership for Patients program. It succeeds the recently concluded Hospital Engagement Networks and will work to reduce overall hospital-acquired…
The Centers for Disease Control and Prevention today warned health care providers and patients about the potential risk of infection from certain devices used during open heart surgery. Stöckert 3T heater-cooler devices, made by LivaNova PLC (formerly Sorin Group Deutschland GmbH), may have been…
CDC Health Advisory: CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
As the new president and CEO of AHA’s Health Research & Educational Trust (HRET), I am thrilled that HRET has been selected as one of 16 national, regional or state hospital associations, Quality Improvement Organizations and health system organizations to continue efforts in reducing…
The Centers for Medicare & Medicaid Services (CMS) Sept. 29 awarded $347 million in contracts to 16 organizations, including the AHA’s Health Research & Educational Trust (HRET), to continue efforts to reduce hospital- acquired conditions and readmissions in the Medicare program.
Click here to view the HEN 2.0 Final Report.
The Centers for Medicare & Medicaid Services today awarded $347 million in contracts to 16 organizations, including the AHA’s Health Research & Educational Trust, to continue efforts to reduce hospital-acquired conditions and readmissions in the Medicare program. The Hospital…
The Centers for Medicare & Medicaid Services is conducting through Sept. 30 a second review and corrections period for the fiscal year 2017 Hospital Acquired Condition Reduction Program due to an error in calculating Clostridium difficile infection performance during the first two quarters of…
The Centers for Medicare & Medicaid Services has announced an error in calculating Clostridium difficile infection performance during the first two quarters of 2014.
This error affects hospital performance in the fiscal year 2017 Hospital Acquired Condition Reduction Program, baseline…
The Food and Drug Administration yesterday alerted pharmacy and nursing professionals to a voluntary recall of seven lots of an injectable drug used to treat certain serious bacterial infections, which may contain glass particulate matter. The Teva Pharmaceuticals Amikacin Sulfate Injection…